Overall survival of patients and the presence of A frequent ccRCC-associated HLA class I presented peptides; B frequent ccRCC-associated HLA class II presented peptides; and C combined frequent ccRCC-associated HLA class I and class II presented peptides. The conditional interference tree model was used to determine the optimal cutoffs with respect to overall survival using the R packages survival [1] and party [2] . P-values were computed from absolute peptide numbers by Wald test. [3] . Other signatures that were assessed are: B cells, macrophages, neutrophils, NK cells, pDCs, MHC class I, co-stimulation APC, co-stimulation T cell, co-inhibition APC, co-inhibition T cell, type I interferon response, type II interferon response, and cytolytic activity [3] . None of those correlated significantly with the presence of EGLN3-derived peptides. Wilcoxon rank-sum test pvalues are shown in the plots. . S2 ). The scheme below depicts the EGLN3 gene region. Sites that were chosen for further analysis in patient cohort 1 are marked by an asterisk. B Methylation profiles in patient cohort 1 analyzed by MALDI-TOF MS of bisulfite treated DNA as described previously [4] . The site cg21218561 was chosen for analysis in the cohort, in addition to the sites marked above. C Correlation plots of EGLN3 gene expression and DNA methylation at the indicated CpG sites in patient cohort 1. Spearman correlation coefficients are printed in the graphs. 
